| Dr Neelofar Khalid Butt, MD | |
|
73 Market St, Yonkers, NY 10710 | |
| (914) 607-4730 | |
| (914) 607-4731 |
| Full Name | Dr Neelofar Khalid Butt |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 73 Market St, Yonkers, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023131620 | NPI | - | NPPES |
| 03106452 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 243633 (New York) | Primary |
| Entity Name | Westchester Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881653822 PECOS PAC ID: 6406752963 Enrollment ID: O20031208000533 |
News Archive
Reporting of new cases of HIV started in 2001 and since then there has been a steady rise and stability of numbers. In 2018 for the first time in nearly two decades, researchers have reported number of new cases to be below 2,000 over the year. This is a record 67 percent decline in the numbers since 2001, says the report. Further the decline in the numbers has been seen in nearly all age groups between 2017 and 2018.
Scioderm announced its investigational product SD-101 has received Breakthrough Therapy designation by the U.S. Food and Drug Administration for the treatment of patients with inherited Epidermolysis Bullosa.
1 in 3 people over the age of 65 suffer from a fall every year in Ireland. Two-thirds of this group fall again within 6 months, leading to risk of hospitalisation and significant health decline. Today in St James's Hospital, Dublin, Seán Sherlock T.D., Minister for Research and Innovation, launched the TRIL Clinic's novel suite of technologies that could potentially increase accuracy in the assessment of falls risk in older people.
Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.
› Verified 8 days ago
| Entity Name | Sun River Health Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568526838 PECOS PAC ID: 6608783568 Enrollment ID: O20040714000375 |
News Archive
Reporting of new cases of HIV started in 2001 and since then there has been a steady rise and stability of numbers. In 2018 for the first time in nearly two decades, researchers have reported number of new cases to be below 2,000 over the year. This is a record 67 percent decline in the numbers since 2001, says the report. Further the decline in the numbers has been seen in nearly all age groups between 2017 and 2018.
Scioderm announced its investigational product SD-101 has received Breakthrough Therapy designation by the U.S. Food and Drug Administration for the treatment of patients with inherited Epidermolysis Bullosa.
1 in 3 people over the age of 65 suffer from a fall every year in Ireland. Two-thirds of this group fall again within 6 months, leading to risk of hospitalisation and significant health decline. Today in St James's Hospital, Dublin, Seán Sherlock T.D., Minister for Research and Innovation, launched the TRIL Clinic's novel suite of technologies that could potentially increase accuracy in the assessment of falls risk in older people.
Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Neelofar Khalid Butt, MD 2700 Westchester Ave, Purchase, NY 10577-2547 Ph: (914) 607-5730 | Dr Neelofar Khalid Butt, MD 73 Market St, Yonkers, NY 10710 Ph: (914) 607-4730 |
News Archive
Reporting of new cases of HIV started in 2001 and since then there has been a steady rise and stability of numbers. In 2018 for the first time in nearly two decades, researchers have reported number of new cases to be below 2,000 over the year. This is a record 67 percent decline in the numbers since 2001, says the report. Further the decline in the numbers has been seen in nearly all age groups between 2017 and 2018.
Scioderm announced its investigational product SD-101 has received Breakthrough Therapy designation by the U.S. Food and Drug Administration for the treatment of patients with inherited Epidermolysis Bullosa.
1 in 3 people over the age of 65 suffer from a fall every year in Ireland. Two-thirds of this group fall again within 6 months, leading to risk of hospitalisation and significant health decline. Today in St James's Hospital, Dublin, Seán Sherlock T.D., Minister for Research and Innovation, launched the TRIL Clinic's novel suite of technologies that could potentially increase accuracy in the assessment of falls risk in older people.
Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.
› Verified 8 days ago
Dr. Oliver R Cartano, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 984 N. Broadway Suite 506, Yonkers, NY 10701 Phone: 914-963-7668 Fax: 914-963-7669 | |
Dr. Karen Fischer, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 919 N Broadway, Yonkers, NY 10701 Phone: 914-968-1900 | |
Dr. Thomas A Angello, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 73 Market St, Yonkers, NY 10710 Phone: 914-423-7700 Fax: 914-423-2805 | |
Dr. Michael Snyder, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 73 Market St, Yonkers, NY 10710 Phone: 914-305-2725 Fax: 914-607-6241 | |
Dr. Lenore Self Katkin, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1254 Central Park Ave, Yonkers, NY 10704 Phone: 914-423-7700 Fax: 914-424-2805 | |
David Andre' Levi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 984 N Broadway, Suite 315, Yonkers, NY 10701 Phone: 914-965-3670 Fax: 914-965-7857 |